One in three children diagnosed with brain cancer won’t survive.
This heartbreaking stat drives researchers at the Children’s Brain Cancer Centre (CBCC), a centre we’ve proudly supported alongside the Queensland Children's Hospital’s Children's Hospital Foundation for the past seven years.
Today we handed over a $1.5 million cheque to the cause – $1 million from state lottery taxes to the Children’s Hospital Foundation to support sick kids and their families, and $500,000 from The Lott by Golden Casket unclaimed prizemoney to CBCC to fund more world-leading research into paediatric brain cancer, treatment and survivorship.
A hallmark of the centre is the emphasis on moving discovery science into the clinic. Researchers recently discovered that the drug CT-179 could delay the recurrence of the tumour medulloblastoma in laboratory models. The finding is now set to be moved to the clinic, leading to new combination therapies that are less toxic, more effective and improve outcomes for young patients.
Children’s Hospital Foundation CEO Lyndsey Rice said investment from long-term partners such as The Lott was vital to changing the odds for kids with the toughest diagnoses.
“Unlike many other cancers, progress in childhood brain cancer has been painfully slow,” she said.
